ACMG 2025 Visit Us At Booth #501

American College of Medical Genetics and Genomics


Ambry Genetics is a pround sponsor of the 2025 ACMG Annual Meeting. We invite you to visit us at booth 501 to learn more about Ambry's new Exome Testing and Patient for Life and meet our experts in the booth.

Check out our posters and presentations!

We're Excited For You to Join Us

Meet the Experts

Wednesday, March 19 5:00pm

Booth #501 1201 S. Figueroa Street, Los Angeles, CA 90015 US

Meet Ambry Scientific Experts at ACMG! We'll be at the booth #501. Stop by or register using the link below.

  • Stacey Wong - Clinical Scientist II (Gene Team - GDV)
  • Ashley Marsh - Variant Assessment Scientist II (Variant Team)
  • Marissa Russel - Health Plans Director, Policy Specialist (Market Access)
  • Carrie Horton - Clinical Strategy Manager, Clinical Research & Collaborations (RNA) 
  • Rob Pilarski - Medical Affairs Director (EducateNext)
  • Jess Gage - Genomic Science Liaison II (Exome Reveal)
RSVP

Research

Contact an Author

Scientific Posters

Poster # P445

Thursday, March 20, 2025 10:30 - 11:30am

Sara M. Berger, Jamie Weyandt, Marcy E. Richardson, Jose Andres Morales. Beyond NGS: Detailed analysis of Sanger, MLPA and RNA confirms tuberous sclerosis complex in clinically diagnosed patients.

Poster # P749

Thursday, March 20, 2025 10:30 - 11:30am

Matthew P. Johnson, Ashley P.L. Marsh, Laura I. Hudish, Marcy E. Richardson, Steven M. Harrison. BS1/BA1 thresholds derived from disease-specific genetic architectures result in decreased rates of VUS in clinically relevant genes.

Poster # P673

Thursday, March 20, 2025 10:30 - 11:30am

Victoria Ellis, Abbey Jamison, Colin Young, Marcy E. Richardson, Rachid Karam, Sami Belhadj. RNA analysis and long read sequencing identify causative APC complex rearrangement in unsolved FAP case.

Poster # P127

Thursday, March 20, 2025 10:30 - 11:30am

Marissa Russell, Greg Nogle, Timothy Komala, Lily Hoang, Amal Yussuf, Robert Pilarski. The impact of discrepant payor policies from one lab benefits manager on patient access to genetic testing.

Poster # P098

Friday, March 21, 2025 10:30 - 11:30am

Ashley P.L. Marsh, Jennifer Herrera-Mullar, Cassidy Carraway, Cynthia Martinez, Felicia Hernandez, Emily Kudalkar, Marcy E. Richardson. Characterization of RPS20-related colorectal cancer predisposition: A case series from a multigene panel testing cohort.

Poster # P168

Friday, March 21, 2025 10:30 - 11:30am

Grace E. VanNoy, Brooklynn Gasser, Robert Pilarski, John Ranola, Meghan C. Towne. Diagnostic yield of exome sequencing in adults with rare disease: An eight-year retrospective study.

Poster # P114

Friday, March 21, 2025 10:30 - 11:30am

Emily Maxwell, Ayanna Boyce, Caitlin Reid, Ashley P.L. Marsh, Kevin Beezhold, Timothy Komala, Katie Lang, Marcy E. Richardson, Colby L. Chase. Over-representation of PMS2CL pseudogene interference in PMS2 testing in a non-European cohort.

Poster # P290

Friday, March 21, 2025 10:30 - 11:30am

Grace VanNoy, Jessica Gage, Jessica Grzybowski, Shoji Ichikawa, Emily Kudalkar, Catherine Schultz, Jesus Ramirez Castano, Brooklynn Gasser, Melissa Holman, Carrie Horton, Kevin Lam, Melissa Samons, Marcy E. Richardson, Heather Zimmermann. RNA and reclassification: Assessing RNA data in rare disease.

Oral Presentations

Session # Exhibit theater presentation, #1

Thursday, March 20, 2025 11:55 - 12:25pm

Steven M. Harrison, PhD, FACMG. Maximizing Clinical Utility of Exomes: Greater Than The Sum Of Its Parts

Get in Touch With Us While You are Here

Set up a Meeting

Our Blog

Read our blog on why Ambry is using evidence-based quality testing.

Read More

Search Results

Start your search...